ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2,4,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
3,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
4,1,Hypoplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
7,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
7,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
7,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
8,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
9,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
13,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
14,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
14,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
15,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,1,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
16,2,Retinal dystrophy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
17,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
17,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
18,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
19,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
20,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
21,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
22,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
22,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
22,5,Headache,Headaches NEC,Headaches,Nerv,N
22,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
23,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
24,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
24,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
25,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
25,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
26,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
28,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
29,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
31,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
32,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
33,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
33,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
33,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
33,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
33,10,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
33,11,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
33,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
34,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
34,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
37,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
38,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,2,Headache,Headaches NEC,Headaches,Nerv,N
39,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
39,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
39,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
39,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
40,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
40,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
41,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
42,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
43,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
44,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
44,3,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
45,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
45,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
47,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
49,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
49,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
49,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
50,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
52,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
52,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
52,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
52,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
54,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
55,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
55,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
56,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
57,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
58,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
59,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
59,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
59,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
59,6,Headache,Headaches NEC,Headaches,Nerv,N
59,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
59,8,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
60,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
60,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
60,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
62,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
62,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
62,3,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
62,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
63,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
64,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
64,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
64,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
64,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
64,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
64,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
67,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
68,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
68,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
69,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,2,Headache,Headaches NEC,Headaches,Nerv,N
70,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
70,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
70,6,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
71,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
71,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
72,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
73,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
73,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
73,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
75,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
75,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
77,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
77,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
77,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
78,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
78,4,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
78,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
79,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
80,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
81,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
82,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
82,2,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
83,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
84,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
85,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
85,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
85,3,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
85,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
85,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
85,7,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
85,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
85,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
85,10,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
85,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,14,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
85,15,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
85,17,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
86,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
87,1,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
88,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
89,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
89,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
89,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
90,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
90,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
90,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
90,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
90,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
91,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
92,1,Pernicious anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
93,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
93,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
93,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
93,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
94,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
94,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
94,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
95,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
96,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
97,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
98,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
99,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
99,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
100,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
101,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
102,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
102,2,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
102,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
102,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
103,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
104,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
104,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
104,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
104,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
104,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
104,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
104,9,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
104,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
104,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,12,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
104,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
105,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
106,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
106,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
107,2,Ear malformation,Ear disorders congenital NEC,Ear and labyrinthine disorders congenital,Cong,N
108,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
108,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
109,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
109,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
110,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
110,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
111,2,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
112,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
112,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
113,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
113,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
114,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,3,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
114,4,Headache,Headaches NEC,Headaches,Nerv,N
114,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
114,7,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
114,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,9,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
115,1,Headache,Headaches NEC,Headaches,Nerv,N
115,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
115,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
115,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
116,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
116,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
116,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
116,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
116,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
116,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
116,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
116,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
116,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
116,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
116,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
117,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
117,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
117,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
118,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
118,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
118,3,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
118,4,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
119,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
120,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
120,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
121,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
122,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
123,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
123,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
124,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
125,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
126,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
127,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
128,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
129,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
130,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
131,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
132,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
132,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
133,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
134,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
134,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
134,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
134,4,Laryngitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
134,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
134,6,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
134,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
135,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
136,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
136,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
136,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
138,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
140,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
141,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
141,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
141,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
142,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
142,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
142,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
143,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
144,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
145,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
145,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
146,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,1,Hyperinsulinaemic hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
148,1,Hyperinsulinaemic hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
149,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
149,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
150,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
150,3,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
150,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
150,5,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
151,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
151,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
151,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
151,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
151,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
152,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
153,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
153,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
153,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
153,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
154,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
154,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
155,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
155,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
155,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
155,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
155,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,7,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
155,8,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
155,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
156,1,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
156,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
156,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
157,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
158,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
159,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
159,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
160,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
161,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
161,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
162,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
162,2,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
162,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
162,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
162,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
162,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
163,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
164,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
164,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
164,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
164,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
165,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
165,2,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
166,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
166,2,Respiratory disorder neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
167,1,Viral skin infection,Viral infections NEC,Viral infectious disorders,Infec,N
168,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
168,2,Headache,Headaches NEC,Headaches,Nerv,N
168,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
169,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
170,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
170,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
171,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
171,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
171,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
173,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
173,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
173,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
173,6,Oropharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
173,7,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
173,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,9,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
174,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
174,2,Precursor T-lymphoblastic lymphoma/leukaemia,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
175,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,4,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
176,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
176,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
177,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
177,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
177,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
177,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
177,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
177,8,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
178,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
178,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
178,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
179,1,Angiocentric lymphoma,Angiocentric lymphomas,Lymphomas non-Hodgkin's T-cell,Neopl,N
179,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
180,1,Clonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
180,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
180,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
180,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
180,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
180,6,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
180,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
180,8,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
180,9,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
181,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
181,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
181,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,1,Eczema nummular,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
183,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
184,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
184,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
185,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
185,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
185,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
186,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
186,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
186,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
187,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
187,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
187,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
187,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
187,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
188,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
188,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
188,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
188,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
189,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
189,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
189,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
190,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
193,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
193,3,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
193,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
195,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
197,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
197,2,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
197,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
198,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
198,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
199,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
200,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
201,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
201,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
201,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
201,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
201,6,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
202,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
202,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
203,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
203,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
204,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
204,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
204,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,4,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
204,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
204,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
204,7,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
204,8,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
204,9,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
204,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
204,11,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
204,12,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
204,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
204,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
205,1,Acute monocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
205,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
205,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
205,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
205,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
206,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
206,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
206,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
206,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
206,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
206,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
206,8,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
206,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
206,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
206,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
207,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
208,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
208,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
208,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
208,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
209,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
209,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
211,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
212,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
213,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
215,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
218,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
218,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
218,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
219,1,Acne,Acnes,Skin appendage conditions,Skin,N
219,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
219,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
219,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
220,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
221,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
221,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
221,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
221,4,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
222,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
222,2,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
222,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
222,4,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
223,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
223,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
223,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
223,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
224,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
224,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
224,3,Hepatic atrophy,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
224,4,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
224,5,Non-cirrhotic portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
224,6,Portal fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
224,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
224,8,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
225,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
225,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
226,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
226,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
227,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
227,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
227,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
228,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
228,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
229,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
229,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
229,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
229,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
229,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
229,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
229,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
229,8,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,9,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
230,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
231,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
232,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,1,Acne,Acnes,Skin appendage conditions,Skin,N
233,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
234,1,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
234,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
234,3,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
234,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
235,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
235,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
235,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
236,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
237,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
238,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
239,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
239,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
240,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
240,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
240,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
240,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
240,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
240,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
241,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
241,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
241,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
241,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
241,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
241,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
242,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
244,1,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
244,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
245,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
245,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
245,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
245,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
245,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
246,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
247,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
247,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
247,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
248,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
248,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
248,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
248,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
249,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
249,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
249,3,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
250,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
250,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
250,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
250,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
250,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
250,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
250,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
250,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
251,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
251,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
252,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
252,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
253,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
254,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
254,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
255,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
256,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
257,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
257,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
258,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
258,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
258,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
259,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
259,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
259,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
259,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
259,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
259,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
260,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
261,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
261,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
261,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
262,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
263,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
263,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
264,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
265,1,Headache,Headaches NEC,Headaches,Nerv,N
266,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
266,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
267,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
268,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
268,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
268,3,Headache,Headaches NEC,Headaches,Nerv,N
268,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
269,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
270,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
272,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
273,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
273,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
273,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
273,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
273,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
273,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
274,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
274,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
275,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
276,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
277,1,Headache,Headaches NEC,Headaches,Nerv,N
277,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
278,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
279,1,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
279,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
280,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
280,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
280,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
280,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
280,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
281,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
281,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
282,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
282,2,Anal fissure,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
282,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
282,4,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
282,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
283,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
283,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
284,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
284,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
285,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
286,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
287,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
287,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
287,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
287,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,1,Acne,Acnes,Skin appendage conditions,Skin,N
288,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
288,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
289,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
290,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
290,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
290,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
290,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
290,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
291,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
291,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
291,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
291,4,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
291,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
291,6,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
291,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
292,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
294,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
294,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
295,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
295,2,Red blood cell sedimentation rate,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
296,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
296,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
296,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
296,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
296,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
296,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
296,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
296,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
296,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
296,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
296,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
296,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
296,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
297,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
297,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
297,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
297,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
297,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
298,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
298,2,Placental transfusion syndrome,Haematological disorders,Haematological disorders NEC,Blood,N
298,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
299,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
299,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
300,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
300,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
301,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
301,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
301,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
302,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
302,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
302,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
303,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
303,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
303,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
303,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
303,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
304,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
304,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
304,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
307,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
307,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
308,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
308,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
309,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
309,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
309,3,West Nile viral infection,Flaviviral infections,Viral infectious disorders,Infec,N
310,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
311,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
312,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
313,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
314,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
314,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
315,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
316,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
316,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
317,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
318,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
318,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
319,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
319,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
319,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
320,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
321,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
322,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
322,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
322,3,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
322,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
323,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
323,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
323,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
323,6,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
323,7,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
325,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
325,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
326,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
327,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
327,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
328,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
329,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
329,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,3,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
329,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
329,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
329,6,Headache,Headaches NEC,Headaches,Nerv,N
329,7,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
329,8,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
329,9,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
329,10,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
329,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
329,12,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
329,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
329,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
329,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,16,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
330,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
330,2,Karyotype analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
330,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
331,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
331,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
332,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
333,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
333,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
333,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
333,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
